Abstract
Transgenesis is an important tool for exploring gene expression and function. The myocyte enhancer factor 2a (mef2a) gene encodes a member of the Mef2 protein family that is involved in vertebrate skeletal, cardiac, and smooth muscle development and differentiation during myogenesis. According to studies on human and animal models, mef2a is highly expressed in the heart and somites. To explore the potential of mef2a as a tool for selective labeling of muscle cells in living zebrafish embryos, we constructed a transgene mef2aa:EGFP to induce the expression of green fluorescent protein (GFP) under the control of mef2a promoter. A ~2-kb DNA fragment, upstream of the translational start site of mef2aa, was identified to drive muscle-specific expression of EGFP in zebrafish embryos. Interestingly, the cranial muscles, abductor muscle, and adductor muscle were clearly labeled with EGFP in the established line Tg(mef2aa:EGFP) ntu803. In addition, we showed that mef2aa mRNA was highly present in adult zebrafish heart, but not the skeleton muscle, whereas it was expressed in both embryonic heart and myotome, suggesting that mef2a is vital to the function of adult heart in vertebrates.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The myocyte enhancer factor 2 (Mef2) proteins belong to the ancient MADS family of transcription factors (Shore and Sharrocks 1995) and play an important role in morphogenesis and myogenesis of skeletal, cardiac, and smooth muscle cells (Olson et al. 1995). The N-terminal end of MEF2 factors contains a Mef2 domain and a highly conserved MADS-box, which together mediate DNA binding, dimerization, and co-factor interactions (Potthoff and Olson 2007; Black and Olson 1998; McKinsey et al. 2002), while the C-terminal regions of Mef2 proteins function as transcriptional activation domains (Potthoff and Olson 2007; Martin et al. 1994). There are four vertebrate Mef2 genes, Mef2a, Mef2a-b, Mef2a-c, and Mef2a-d, which are expressed in distinct, but overlapping patterns during embryogenesis through adulthood (McKinsey et al. 2002). Zebrafish is a popular model system for studying early embryo development and human disease (Lieschke and Currie 2007). It has also become an attractive model for studying regeneration of various tissues and organs, such as fins, heart, spinal cord, brain, and muscle (Gemberling et al. 2013). To fully exploit zebrafish in these studies, great emphasis has been placed on generation of fish lines that express desired transgenes, usually the fluorescence proteins, in either specific subsets of cells and tissues or a wide range of cells (Burket et al. 2008). These lines allow application of high-resolution imaging in vivo on zebrafish model. In addition, studies in zebrafish demonstrated that mef2aa is highly expressed in the heart (Wang et al. 2005) and somites (Wang et al. 2006) during zebrafish embryogenesis. Currently, we aimed to construct a transgene mef2aa:EGFP to induce the expression of EGFP in cardiomyocytes and muscle cells under the control of mef2aa promoter. The generation of Tg(mef2aa:EGFP) line will provide the new insights of understanding the mef2a expression in embryo and facilitate further analysis of the roles of mef2a in vivo during the development and tissue regeneration in adults.
Materials and methods
Zebrafish
Zebrafish (AB strain) were raised and maintained at 28.5 °C as previously described (Huang et al. 2013; Wang et al. 2015, 2016). Embryos were collected through natural mating. Embryonic stages were determined according to time post-fertilization and characteristics described by Kimmel et al. (1995). Embryos after 24 h post-fertilization (hpf) were treated with 0.2 mM 1-phenyl-2-thio-urea (PTU, Sigma) to prevent the pigmentation for further observation and imaging. Zebrafish embryos used for whole-mount in situ hybridization were collected at various stages, fixed with 4 % paraformaldehyde (PFA) in phosphate-buffered saline (PBS) overnight at 4 °C or 2 h at room temperature, washed with PBST, dehydrated in methanol, and stored at −20 °C until use. Embryos at stages earlier than 24 hpf were dechorionated after fixation, prior to storage.
Construction of mef2a:EGFP plasmid
Mef2aa promoter fragments (2044 bp) were amplified from the adult zebrafish genomic DNA by polymerase chain reaction (PCR) (Primers are listed in Table S1). Subsequently, the fragments were sub-cloned into pENTR™5′-TOPO® vector (Life Technologies) to produce 5′ Entry clone. pME-EGFP plasmid and p3E-polyA plasmid were obtained from Tol2Kit (Kwan et al. 2007). Three entry clones and the pDestTol2pA2 destination vector were used to generate the expression construct by LR recombination reaction as described in the Multisite Gateway Manual (Life Technologies).
RNA synthesis
Transposase RNA was generated using the pCS2-transposase plasmid as a template. Plasmid DNA was linearized with restriction endonuclease KpnI (NEB) and purified using the Zymoclean™ Gel DNA Recovery kit from agarose gels. Then, the mMESSAGE mMACHINE (Ambion, Life Technologies) was used to synthesize the capped RNA in vitro. The synthesized transposase RNA was purified by the RNeasy® MinElute® Cleanup kit (Qiagen).
RNA extraction, reverse transcription, and PCR
Tissue was homogenized and frozen in TRIzol Reagent (Life Technologies) and stored at −80 °C. The RNA was extracted following the manufacturer’s instruction. 1 µg of RNA was reverse transcribed into cDNA by the use of Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the manufacturer’s instructions. Synthesized cDNA was stored at −20 °C. All PCR amplifications were carried out in a total volume of 50 µl using specific primers and Advantage 2 Polymerase Kit (Clontech). The RT-PCR primers for zebrafish mef2aa and ef1α are listed in Table S1.
Microinjection of plasmid DNA and transposase RNA
The plasmid DNA and transposase RNA were mixed and microinjected into eggs at single-cell or two-cell stage. Approximately, 75 pg of plasmid DNA and 25 pg of transposase RNA were injected per embryo. Post-injection embryos were incubated at 28 °C in incubator.
Transgenic zebrafish screening
Injected embryos were screened through examining fluorescence expression using the stereo fluorescence microscopy (Olympus, MVX10; Zeiss, SteREO Discovery V20). Founders were raised until sexually mature and individually mated with wild-type (WT) fish, and the offspring were examined for fluorescence expression in muscle cells. F1 embryos were obtained from one of the positive founders and raised. Eight surviving positive male F1 fish were mated with wild-type females to generate F2 fish. F2 males were mated with F2 females to breed F3 generation.
Preparation of mef2aa RNA probe and whole-mount in situ hybridization (WISH)
The cDNA fragment (approximately 500 bp) of zebrafish mef2a was amplified by PCR. The primers used are listed in Table S1. Digoxigenin-labeled RNA probe was transcribed in vitro using T7 RNA polymerase, with the linearized pGEM®-T Easy vector (Promega) containing the DNA fragment of zebrafish mef2aa. The WISH procedure to detect mef2aa expression was carried out as described previously (Huang et al. 2013).
Imaging
Embryos subjected to whole-mount in situ hybridization were mounted in 75 % glycerol/PBST and photographed under a stereomicroscope (Olympus, MVX10) with DP71 camera. A Leica TCS SP5 was used for confocal imaging. Embryos were embedded in 0.8 % low melting point agarose dissolved in E3 medium with 0.03 % tricaine methanesulfonate (MS222, Sigma). All images acquired were compiled and edited using Adobe Photoshop and Illustrator software.
Results
Establishment of Tg(mef2aa:EGFP) zebrafish
There are two mef2a genes in zebrafish, mef2aa and mef2ab. It was reported that mef2aa was expressed in developing heart and somites (Wang et al. 2005, 2006), whereas mef2ab gene was not detected in zebrafish heart and somites at the corresponding stages (Yogev et al. 2013). Therefore, we choose to generate Tg(mef2aa:EGFP) transgenic zebrafish line that expresses EGFP in muscle cells. Firstly, we generated the mef2aa:EGFP transgenic construct (Fig. 1) containing a pair of Tol2 elements with mef2aa regulatory elements and the gene encoding EGFP using the multisite gateway system (Fig. 1; Figure S1). Then, the synthetic transposase mRNA and the expression construct were co-injected into zebrafish fertilized eggs at single-cell stage (Fig. 1). A fragment of 2044-bp DNA sequence was identified to drive muscle-specific expression of EGFP in zebrafish embryos. Founders were raised until sexually mature and individually mated with WT fish line. Of the 67 founders, 20 germ-line transmitted transgenic fish were identified. F1 embryos obtained from one of the positive founders, which were screened through examining the expression of fluorescence under a fluorescence stereomicroscope, and the positive F1 fish were raised. Eight surviving positive male F1 fish were mated with WT females to generate F2 fish. About 50 % of F2 offspring embryos carried EGFP expression, suggesting that the germline transmission rate of transgene complied with Mendelian inheritance law. F2 males were mated with F2 females to breed F3 generation. Finally, the Tg:(mef2aa:EGFP) ntu803 transgenic line was confirmed by around 75 % fluorescence induction in the F3 generation.
EGFP expression in Tg(mef2aa:EGFP) ntu803 zebrafish embryo in vivo
We examined the green fluorescence in Tg(mef2aa:EGFP) ntu803 zebrafish embryos through confocal imaging analysis. It was observed that GFP was weakly expressed at 75 % epiboly stage (Fig. 2a). In 5-somite and 20-somite stage embryos, we found GFP was present in telencephalon and myotomes (Fig. 2b, c). The transgene expression at these stages was similar to the endogenous expression of mef2aa shown through whole-mount in situ hybridization analysis (Fig. 2d). At 24 hpf stage, GFP was strongly expressed in myotomes and heart (Fig. 2e, e′). The endogenous expression of mef2aa was also detected in myotomes and heart at the corresponding stage (Fig. 2f). At 36 hpf, 3 dpf, and 4 dpf stage, the GFP expression in heart and myotomes increasingly remained (Figs. 2g, h, 3a, b, c, c′, c″). In addition, GFP expression was detected in head muscle including intermandibularis anterior and posterior (INTM-A and INTM-P), interhyoideus (INTE), hyoideus inferior (HH-INF), sternohyoideus (SH), ocular muscles (OM), levator arcus palatini (LEV-AP), levator operculi (LEV-OP), dilatator operculi (DIL-OP), adductor hyomandibulae (AD-HYO) (Fig. 3d, d′). The pectoral fin muscles were also clearly labeled with EGFP including abductor muscle (ABM) and adductor muscle (ADM) (Fig. 3e, e′, e″).
EGFP expression in adult Tg(mef2aa:EGFP) ntu803 zebrafish heart and myotomes
Next, we examined GFP expression in adult Tg(mef2aa:EGFP) ntu803 zebrafish heart and myotomes. We dissected the heart by surgery and found that EGFP was highly present in adult zebrafish heart (Fig. 4a, b), but not in bulbus arteriosus (Fig. 4b). Cryostat sections of the Tg(mef2aa:EGFP) ntu803 zebrafish heart confirmed GFP expression in cardiomyocytes (Fig. 4c). In the transection analysis of zebrafish trunk, we demonstrated that GFP expression in myotome was weakly distributed in restricted region (Fig. 4d, e). RT-PCR analysis revealed that the endogenous expression of mef2aa in adult zebrafish heart is higher than that in brain and myotome (Fig. 4f), which supports that mef2aa is highly expressed in adult heart but not in skeleton muscle.
Discussion
Currently, we generated a Tg(mef2aa:EGFP) ntu803 transgenic zebrafish line that expresses EGFP in muscle cells. Mef2a transcripts are expressed in a wide array of tissues in mammals, while MEF2A protein appears to be considerably more restricted and is abundant in skeletal muscle, heart, and brain tissues (Suzuki et al. 1995) Accumulating evidence indicates that Mef2a is associated with cardiovascular and muscle development (Estrella et al. 2015). In addition, knockdown of mef2a in zebrafish embryos impairs the cardiac contractility (Wang et al. 2005) and posterior somite development (Wang et al. 2006). Our data are consistent with these findings that mef2a is highly expressed in developing heart and muscles. A loss-of-function mutation in the human Mef2a causes an autosomal dominant form of coronary artery disease, including its most serious complication myocardial infarction (Wang et al. 2003; Bhagavatula et al. 2004). Most mice lacking Mef2a die suddenly within the immediate perinatal period and exhibit pronounced dilation of the right ventricular, myofibrillar disarray and activation of a fetal cardiac gene program. The few Mef2a knock out mice that survives to adulthood is also susceptible to sudden cardiac death with mitochondrial deficiency (Naya et al. 2002). It was revealed that the level of mef2aa transcripts in adult zebrafish heart is higher than that in myotome. However, mef2aa was expressed in both heart and myotome in zebrafish embryos. Taken together, these observations suggest that mef2a is vital to the function of adult heart in vertebrates. Interestingly, the cranial muscles and pectoral fin muscles were clearly labeled with EGFP in Tg(mef2aa:EGFP) ntu803 line embryos, which allows high-resolution imaging of these muscles in vivo and promotes further studies of the role of mef2a in the development of these muscles. In addition, Mef2a was revealed to involve skeletal muscle regeneration in mice (Liu et al. 2014). It will be of interest to explore the expression and function of mef2a during skeletal muscle regeneration in the established Tg(mef2aa:EGFP) ntu803 line adults.
References
Bhagavatula MR et al (2004) Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 13(24):3181–3188
Black BL, Olson EN (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14:167–196
Burket CT et al (2008) Generation and characterization of transgenic zebrafish lines using different ubiquitous promoters. Transgenic Res 17(2):265–279
Estrella NL et al (2015) MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation. J Biol Chem 290(2):1256–1268
Gemberling M et al (2013) The zebrafish as a model for complex tissue regeneration. Trends Genet 29(11):611–620
Huang Y et al (2013) Nonmuscle myosin II-B (myh10) expression analysis during zebrafish embryonic development. Gene Expr Patterns 13(7):265–270
Kimmel CB et al (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203(3):253–310
Kwan KM et al (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236(11):3088–3099
Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8(5):353–367
Liu N et al (2014) Requirement of MEF2A, C, and D for skeletal muscle regeneration. Proc Natl Acad Sci USA 111(11):4109–4114
Martin JF et al (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol Cell Biol 14(3):1647–1656
McKinsey TA, Zhang CL, Olson EN (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27(1):40–47
Naya FJ et al (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 8(11):1303–1309
Olson EN, Perry M, Schulz RA (1995) Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol 172(1):2–14
Potthoff MJ, Olson EN (2007) MEF2: a central regulator of diverse developmental programs. Development 134(23):4131–4140
Shore P, Sharrocks AD (1995) The MADS-box family of transcription factors. Eur J Biochem 229(1):1–13
Suzuki E et al (1995) Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol Cell Biol 15(6):3415–3423
Wang L et al (2003) Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302(5650):1578–1581
Wang YX et al (2005) Requirements of myocyte-specific enhancer factor 2A in zebrafish cardiac contractility. FEBS Lett 579(21):4843–4850
Wang Y et al (2006) Myocyte-specific enhancer factor 2A is essential for zebrafish posterior somite development. Mech Dev 123(10):783–791
Wang X et al (2015) Egfl6 is involved in zebrafish notochord development. Fish Physiol Biochem 41(4):961–969
Wang X et al (2016) MicroRNA-10a/10b represses a novel target gene mib1 to regulate angiogenesis. Cardiovasc Res 110(1):140–150
Yogev O et al (2013) eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation. PLoS Biol 11(10):e1001679
Funding
This work was supported by National Natural Science Foundation of China 31400918, 31201083, 81570447 and Natural Science Foundation from Jiangsu Province 12KJB180010, BK2012228.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Feng Lv and Chenwen Zhu have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lv, F., Zhu, C., Yan, X. et al. Generation of a mef2aa:EGFP transgenic zebrafish line that expresses EGFP in muscle cells. Fish Physiol Biochem 43, 287–294 (2017). https://doi.org/10.1007/s10695-016-0286-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10695-016-0286-3